Science Explorer Back to mapMap
Discussion
Researcher · MaxCyte (United States) · United States

Linda N. Liu

Linda N. Liu publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Immune Cell Function and Interaction and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-4220-1076 OpenAlex
World rank
#1,176,251
of 7,710,434 ranked researchers
Rank in United States
#378,018
of 1,627,098
Works
84
Citations
2.5k
Citations per work
30.3
h-index
15
i10-index 18Top 48% in Immunology
Linda N. Liu

What does Linda N. Liu research?

Linda N. Liu's work is mostly in Medicine (27%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (24%).

Life Sciences: 40 works · 47.7% of their workImmunology and Microbiology: 20 works · 23.9% of their workImmunology: 20 works · 23.9% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 23.8% of their workMolecular Biology: 14 works · 17.0% of their workBiotechnology: 6 works · 6.8% of their workHealth Sciences: 23 works · 27.2% of their workMedicine: 23 works · 27.2% of their workOncology: 14 works · 17.0% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 5.7% of their workHematology: 4 works · 4.5% of their workEverything else: 21 works · 25.1% of their workTHEIR WORKLinda N. Liu84works
Life Sciences48%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology2023.9%
    2. Biochemistry, Genetics and Molecular Biology2023.8%
    1. Medicine2327.2%
  3. Everything else2125.1%
  1. 1Immunology24% of their works
  2. 2Oncology17% of their works
  3. 3Molecular Biology17% of their works
  4. 4Biotechnology7% of their works
  5. 5Radiology, Nuclear Medicine and Imaging6% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Linda N. Liu's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Natural Killer Cells, NK Cell Recognition, CAR T Cells, Chimeric Antigen Receptor and Gene Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy152 topics
  2. Dendritic Cells91 topic
  3. Immunity91 topic
  4. NK Cell Recognition71 topic
  5. Natural Killer Cells71 topic
  6. CAR T Cells61 topic
  7. Chimeric Antigen Receptor61 topic
  8. Gene Therapy62 topics
  9. Immune Checkpoint Blockade61 topic
  10. PD-1 and PD-L161 topic
  11. Fc Receptors41 topic
  12. Therapeutic Antibodies41 topic
  13. AAV31 topic
  14. BCR-ABL31 topic
  15. Electroporation31 topic
  16. Imatinib31 topic
  17. Irreversible Electroporation31 topic
  18. Viral Vectors31 topic

Where does Linda N. Liu work?

Linda N. Liu's main affiliation in the publication record is MaxCyte (United States), United States.

How many publications and citations does Linda N. Liu have?

OpenAlex counts 84 works and 2,545 citations for Linda N. Liu, an h-index of 15, ranking #1,176,251 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Linda N. Liu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.